Selective androgen receptor modulator

Selective Androgen Receptor Modulators or SARMs are a class of androgen receptor ligands that were developed with the intention of maintaining some of the desirable effects of androgens, such as preventing osteoporosis and muscle loss while reducing risks of undesirable conditions such as prostate cancer. In the late 1990s, the first nonsteroidal SARM, an analog of bicalutamide, was discovered at Imperial Chemical Industries. Although bicalutamide itself is an antiandrogen, its discovery encouraged a search for non-steroidal agonists of androgen receptors, as it was well-known, that small structural changes can transform a receptor antagonist into an agonist (see "Lock and key" model). It was expected, that non-steroidal androgens could provide similar positive effects as anabolic-androgenic steroids, but with fewer side effects. Although some work on SARMs was done as early as 1940s, it was not until the late 1990s, when researchers at Ligand Pharmaceuticals and the University of Tennessee discovered a new class of cyclic, nonsteroidal quinolinones, with a high anabolic activity in skeletal muscles, and variable selectivy in other tissues. At present, there are no SARMs which have been approved for therapeutic use by the U.S. Food and Drug Administration. The binding of ligands to the androgen receptor (AR) results in a conformational change, this consequentially alters surface topology which will lead to tissue-specific gene regulation. This tissue-specific regulation then allows for the selective stimulation or inhibition of the AR; this requires androgen response elements, co-regulators, and transcription factors. Although the exact mechanisms still remain unclear, tissue specificity and complexity of the pathway is known to dictate the transcriptional and cellular response. There have been experiments using a SARMs C-6 and S-23 on male mice as a contraceptive agent. Treatment of osteoporosis has been explored as SARMs have been found to have trophic effects on bone density and mineralization.

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Concepts associés (8)

Séances de cours associées (8)

Selective androgen receptor modulator

Stéroïde anabolisant

Les stéroïdes anabolisants, également connus sous le nom de stéroïdes androgéniques anabolisants ou SAA, sont une classe d'hormones stéroïdiennes liée à une hormone naturelle humaine : la testostérone. Ils augmentent la synthèse des protéines dans les cellules, entraînant une augmentation de tissus cellulaires (anabolisme), en particulier dans les muscles. Les stéroïdes anabolisants ont également des propriétés telles que le développement et l'entretien des caractéristiques masculines comme par exemple la croissance des cordes vocales et la pilosité.

Selective receptor modulator

In the field of pharmacology, a selective receptor modulator or SRM is a type of drug that has different effects in different tissues. A SRM may behave as an agonist in some tissues while as an antagonist in others. Hence selective receptor modulators are sometimes referred to as tissue selective drugs or mixed agonists / antagonists. This tissue selective behavior is in contrast to many other drugs that behave either as agonists or antagonists regardless of the tissue in question.

Récepteurs nucléaires : Coactivateurs et modulation transcriptionnelle

Explore le rôle des coactivateurs dans la modulation transcriptionnelle, l'acétylation des histones, les antagonistes de l'ERa et les actions spécifiques des tissus des récepteurs nucléaires.

Auto-assemblage des protéines et transitions de phase

Déplacez-vous dans l'auto-assemblage des protéines, les transitions de phase et les mécanismes d'agrégation dans des maladies comme la maladie d'Alzheimer.

Dopage sportif : effets physiologiques BIO-450: Molecular endocrinology

Plonge dans l'impact des agents dopants sur la performance sportive et le corps humain, en mettant l'accent sur les risques et les conséquences impliqués.